Global Veterinary Molecular Diagnostics Market Forecast Highlighting Expansion And Competitive Dynamics

June 5, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Is The Market Value Of The Veterinary Molecular Diagnostics Market Projected To Expand During 2026–2030?

The veterinary molecular diagnostics market has shown substantial expansion in recent years. Its valuation is set to increase from $0.7 billion in 2025 to $0.77 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.9%. This past growth can be attributed to the rising incidence of infectious and genetic animal diseases, advancements in molecular biology technology, an increase in companion and livestock animal populations, heightened veterinary awareness and training, and the widespread use of conventional molecular diagnostic kits.

The veterinary molecular diagnostics market size is projected to experience substantial expansion over the next few years. It is anticipated to grow to $1.11 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 9.6%. This expected growth during the forecast period can be attributed to the escalating demand for swift and precise molecular diagnostics, the integration of NGS and high-throughput platforms, the widening scope of veterinary genomics services, the incorporation of AI-driven diagnostic analysis, and an increasing focus on preventive veterinary care through molecular testing. Prominent trends for the forecast period include the broader application of PCR and RT-PCR-based diagnostics, the rising adoption of next-generation sequencing (NGS) in veterinary medicine, the development of multiplex diagnostic kits for infectious diseases, the integration of molecular diagnostics into routine veterinary care, and the availability of automation and high-throughput molecular testing solutions.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20687&type=smp

Which Major Factors Are Contributing To The Development Of The Veterinary Molecular Diagnostics Market?

The high prevalence of zoonotic diseases is expected to propel the growth of the veterinary molecular diagnostics market going forward. Zoonotic diseases are infectious diseases that are transmitted between animals and humans. These diseases can be caused by bacteria, viruses, parasites, or fungi. Common zoonotic diseases include rabies, Lyme disease, salmonellosis, toxoplasmosis, and more. The prevalence of zoonotic diseases is influenced by deforestation, wildlife exploitation, intensive animal farming, biodiversity loss, and human mobility. Veterinary molecular diagnostics help detect zoonotic diseases early in animals, preventing their spread to humans. They also improve disease management by enabling rapid, accurate identification of pathogens. For instance, in December 2025, according to the European Centre for Disease Prevention and Control (ECDC), a Sweden-based government agency, in 2024, the number of reported human cases of key zoonotic diseases such as campylobacteriosis (168,396 cases) and salmonellosis (79,703 cases) continued to increase, reflecting a significant ongoing prevalence of zoonoses in Europe . Therefore, the high prevalence of zoonotic diseases is driving the veterinary molecular diagnostics market.

How Is Segment Classification Applied In The Veterinary Molecular Diagnostics Market?

The veterinary molecular diagnostics market covered in this report is segmented –

1) By Product: Kits And Reagents, Instruments

2) By Animal Type: Companion Animals, Livestock Animals

3) By Application: Infectious Diseases, Genetic Diseases, Other Applications

4) By End-User: Diagnostic Laboratories, Veterinary Clinics, Veterinary Hospitals, Other End-Users

Subsegments:

1) By Kits And Reagents: Polymerase Chain Reaction (PCR) Kits, Reverse Transcription PCR (RT-PCR) Kits, Real-Time PCR Kits, Nucleic Acid Extraction Kits, Enzyme-Linked Immunosorbent Assay (ELISA) Kits, Hybridization Kits, Reagents For Next-Generation Sequencing (NGS)

2) By Instruments: PCR Machines (Thermal Cyclers), Real-Time PCR Machines, Nucleic Acid Analyzers, Gel Electrophoresis Equipment, DNA Sequencers, Automated Liquid Handling Systems, Molecular Imaging Systems

Which Trends Are Supporting The Evolution Of The Veterinary Molecular Diagnostics Market?

Major companies operating in the veterinary molecular diagnostics market are focusing on automation and scalability in diagnostic technologies, such as high-volume testing machines, to improve diagnostic accuracy, increase testing efficiency, and enable faster detection of diseases in animals. High-volume testing machines are advanced diagnostic devices designed to process large quantities of samples efficiently, enabling rapid and accurate analysis in laboratories or clinical settings, particularly useful for large-scale testing. For instance, in June 2023, Iowa State University’s Veterinary Diagnostic Laboratory (VDL), a US-based university, introduced SmartChip, a cutting-edge molecular diagnostic testing device equipped with quantitative polymerase chain reaction (qPCR) testing technology. This innovative device can accommodate more than 5,000 samples on a plate no bigger than a postage stamp. It greatly increases its testing capacity when paired with a 384-sample system equipped with automated handling features. The SmartChip testing utilizes microfluidic technology to identify targets of interest in samples, employing a volume 100 times smaller than that used by the VDL’s standard 96-well machines.

Who Are The Major Companies Operating In The Veterinary Molecular Diagnostics Market?

North America was the largest region in the Veterinary Molecular Diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary molecular diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access The Complete Veterinary Molecular Diagnostics Market Report:

https://www.thebusinessresearchcompany.com/report/veterinary-molecular-diagnostics-global-market-report

Which Region Holds The Largest Share In The Veterinary Molecular Diagnostics Market?

Access a Customized Veterinary Molecular Diagnostics Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=20687&type=smp

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on: